CV5 Capital and Enzyme form a strategic partnership to launch institutional-grade tokenized fund solutions

Foresight News reported that CV5 Capital has announced a strategic partnership with global tokenized financial infrastructure provider Enzyme, which will serve as the foundational technology stack for its tokenized fund issuance and management. CV5 Capital plans to leverage Enzyme Onyx to build, launch, and manage a new generation of investment products, supporting investment strategies across a variety of asset classes including cryptocurrencies, securities, commodities, and US Treasuries.